NZ574231A - Transdermal medicament containing cholecalciferol (vitamin D3) for the treatment of pain and inflammation - Google Patents
Transdermal medicament containing cholecalciferol (vitamin D3) for the treatment of pain and inflammationInfo
- Publication number
- NZ574231A NZ574231A NZ57423109A NZ57423109A NZ574231A NZ 574231 A NZ574231 A NZ 574231A NZ 57423109 A NZ57423109 A NZ 57423109A NZ 57423109 A NZ57423109 A NZ 57423109A NZ 574231 A NZ574231 A NZ 574231A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pain
- vitamin
- cholecalciferol
- treatment
- calciol
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
- Claims
- 2.
- 3.
- 4.
- 5.
- 6. The use of calciol (cholecalciferol) in the manufacture of a medicament for the treatment of neurogenic inflammation and neuropathic pain, wherein the medicament is formulated for transdermal application. The use as claimed in claim 1, wherein the medicament includes a carrier medium suitable for transdermal application, in which calciol (cholecalciferol) is dispersed or dissolved. The use as claimed in claim 2 wherein the carrier medium is selected from the group consisting of:- aqueous-based cream, massaging oil, gel base, ointment, patches, impregnated sheet material. The use as claimed in any one of claims 1 to 3 wherein the calciol (cholecalciferol) is present in a concentration in the range of 5000 lU/gram to 100,000 lU/gram. The use as claimed in claim 4 wherein the calciol (cholecalciferol) is present in a concentration of 40,000 lU/gram. The use as claimed in any one of claims 1 to 5 wherein the calciol (cholecalciferol) is in the form of a powder. The use as claimed in any one of claims 1 to 6 wherein the calciol (cholecalciferol) is dissolved in a plant oil. Jan A Lyftogt " *' *"-neys James & Wells Intellectual Property 7
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ57423109A NZ574231A (en) | 2009-01-16 | 2009-01-16 | Transdermal medicament containing cholecalciferol (vitamin D3) for the treatment of pain and inflammation |
AU2009337184A AU2009337184A1 (en) | 2009-01-16 | 2009-08-13 | Medicament for the treatment of pain and inflammation |
EP09838459A EP2387407A4 (en) | 2009-01-16 | 2009-08-13 | Medicament for the treatment of pain and inflammation |
US13/144,807 US20110274743A1 (en) | 2009-01-16 | 2009-08-13 | Medicament for the Treatment of Pain and Inflammation |
CA2749967A CA2749967A1 (en) | 2009-01-16 | 2009-08-13 | Medicament for the treatment of pain and inflammation |
PCT/NZ2009/000167 WO2010082837A1 (en) | 2009-01-16 | 2009-08-13 | Medicament for the treatment of pain and inflammation |
US13/783,550 US8821921B2 (en) | 2009-01-16 | 2013-03-04 | Vitamin D3 for the transdermal treatment of pain and inflammation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ57423109A NZ574231A (en) | 2009-01-16 | 2009-01-16 | Transdermal medicament containing cholecalciferol (vitamin D3) for the treatment of pain and inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ574231A true NZ574231A (en) | 2011-04-29 |
Family
ID=43903086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ57423109A NZ574231A (en) | 2009-01-16 | 2009-01-16 | Transdermal medicament containing cholecalciferol (vitamin D3) for the treatment of pain and inflammation |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ574231A (en) |
-
2009
- 2009-01-16 NZ NZ57423109A patent/NZ574231A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8821921B2 (en) | Vitamin D3 for the transdermal treatment of pain and inflammation | |
Deltombe et al. | Assessment and treatment of spastic equinovarus foot after stroke: Guidance from the Mont-Godinne interdisciplinary group. | |
Tilton | Management of spasticity in children with cerebral palsy | |
Goff et al. | Diagnosis and treatment of plantar fasciitis | |
US6528076B2 (en) | Topical compositions and methods for treating pain | |
US6248788B1 (en) | Therapeutic method with capsaicin and capasicin analogs | |
Kocabas et al. | Comparison of phenol and alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle for treatment of spastic foot after stroke: a randomized controlled pilot study | |
US9511016B2 (en) | Topical composition for treating pain | |
Ghai et al. | Spasticity–Pathogenesis, prevention and treatment strategies | |
Chughtai et al. | Cryotherapy treatment after unicompartmental and total knee arthroplasty: a review | |
Meals | Peroneal-nerve palsy complicating ankle sprain. Report of two cases and review of the literature | |
EA011708B1 (en) | Administration of trans capsaicin | |
US8541034B2 (en) | Electrical producing creams | |
Jozefczyk | The management of focal spasticity | |
Bavikatte et al. | Approach to spasticity in General practice Approach to spasticity in General practice | |
Yelnik et al. | Disabling overactivity of the extensor hallucis longus after stroke: clinical expression and efficacy of botulinum toxin type A | |
Dietz et al. | The syndrome of spastic paresis | |
Boffeli et al. | Minimally invasive soft tissue release of foot and ankle contracture secondary to stroke | |
NZ574231A (en) | Transdermal medicament containing cholecalciferol (vitamin D3) for the treatment of pain and inflammation | |
Deltombe et al. | The treatment of spastic equinovarus foot after stroke | |
Ko et al. | Spasticity | |
Gulur et al. | Concepts in pain management | |
US20210038669A1 (en) | Composition(s) for Topically Treating Pain | |
KR20230174698A (en) | Pharmaceutical composition for the treatment of pain containing hemp seed oil as an active ingredient | |
Bakheit | Review on management of muscle spasticity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: PHARMACEUTICAL COMPOUNDING NZ LIMITED, NZ Free format text: OLD OWNER(S): JAN ANNE LYFTOGT |
|
PSEA | Patent sealed | ||
ASS | Change of ownership |
Owner name: ANZAMED INTERNATIONAL LIMITED, NZ Free format text: OLD OWNER(S): PHARMACEUTICAL COMPOUNDING NZ LIMITED |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 13 AUG 2016 BY JAMES + WELLS Effective date: 20130805 |
|
ASS | Change of ownership |
Owner name: JAN ANNE LYFTOGT, NZ Effective date: 20160519 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 AUG 2017 BY CREATEIP Effective date: 20160815 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 AUG 2018 BY CREATEIP Effective date: 20170801 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 AUG 2019 BY CREATEIP Effective date: 20180727 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 AUG 2020 BY CREATEIP Effective date: 20190801 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 AUG 2021 BY CREATEIP Effective date: 20200728 |
|
ASS | Change of ownership |
Owner name: HOROPITO LIMITED, GB Effective date: 20201214 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 AUG 2022 BY CREATEIP Effective date: 20210614 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 AUG 2023 BY CREATEIP Effective date: 20220617 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 AUG 2024 BY CREATEIP Effective date: 20230809 |